JTCS St. Jude Medical
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jehangir J. Appoo
Katherine F. Cornelius
Joseph E. Bavaria
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Appoo, J. J.
Right arrow Articles by Bavaria, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Appoo, J. J.
Right arrow Articles by Bavaria, J. E.
Related Collections
Right arrow Great vessels
Right arrow Peripheral vascular

J Thorac Cardiovasc Surg 2006;131:1087-1094
© 2006 The American Association for Thoracic Surgery


Surgery for Acquired Cardiovascular Disease

Thoracic aortic stent grafting: Improving results with newer generation investigational devices

Jehangir J. Appoo, MD, William G. Moser, RN, Ronald M. Fairman, MD, Katherine F. Cornelius, RN, A. Pochettino, MD, Edward Y. Woo, MD, Jibby E. Kurichi, MPH, Jefferey P. Carpenter, MD, Joseph E. Bavaria, MD *

Division of Cardiothoracic Surgery and Division of Vascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pa

Received for publication June 27, 2005; revisions received November 28, 2005; accepted for publication December 22, 2005.

* Address for reprints: Joseph E. Bavaria, MD, Brooke Roberts Professor of Surgery, Division of Cardiothoracic Surgery, 4 Silverstein, Hospital of University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104 (Email: joseph.bavaria{at}uphs.upenn.edu).

OBJECTIVE: Six years ago an endovascular program for repair of descending thoracic aneurysms was established at the University of Pennsylvania. We report on the hypothesis that results are improving with new stent design iterations and describe our experience and lessons learned.

METHODS: From April 1999 to March 2005, 99 patients with descending thoracic aneurysms underwent repair with a first or second-generation commercially produced endograft; 24 patients had an early-generation device, and 75 patients had a late-generation device. Each patient was enrolled as part of 3 distinct Phase I or Phase II Food and Drug Administration-approved clinical trials in accordance with strict inclusion and exclusion criteria.

RESULTS: Mean age was 73.1 years. Symptomatic aneurysms accounted for 42% of the cohort. Mean aneurysm size was 63.7 mm (range: 30-105 mm). Twenty percent of the patients underwent a subclavian carotid transposition or bypass preoperatively to obtain an adequate proximal landing zone. No procedures had to be aborted. In-hospital or 30-day mortality was 5.0%. The incidence of permanent spinal ischemia was 2%. Perioperative vascular complications requiring interposition graft, stent repair, or patch angioplasty occurred in 27% and seemed to be less frequent in the late-generation cohort than the early-generation cohort (22.7% vs 41.7%, respectively, P = .069). At the 30-day follow-up, 23 endoleaks were detected in 22 patients (14.7% in late-generation cohort vs 45.8% in early-generation cohort, P = .001). During the follow-up period, 3 new endoleaks were detected, 3 patients died of aortic rupture, and 10 patients underwent aneurysm-related reintervention. Kaplan-Meier estimated 1, 3, and 5-year survival was 84.5%, 70.5%, and 52.4%, respectively. Freedom from aneurysm-related event, defined as freedom from endoleak, aortic rupture, dissection, or any reintervention on the aorta, was 73%, 69%, and 64% at 1, 3, and 5 years, respectively.

CONCLUSION: Thoracic aortic stent grafting is a safe procedure in selected patients with the added benefit of a low incidence of paraplegia. However, there is an incidence of late complications and reinterventions. This risk requires further quantification and must be balanced against the benefits of a minimally invasive approach with low perioperative morbidity and mortality. Results are improving as technology evolves and our level of experience increases. Radiologic follow-up is mandatory.



Abbreviations and Acronyms CT = computed tomography; DTA = descending thoracic aneurysm; FDA = Food and Drug Administration





This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Marui, T. Mochizuki, T. Koyama, and N. Mitsui
Degree of fusiform dilatation of the proximal descending aorta in type B acute aortic dissection can predict late aortic events.
J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1163 - 1170.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The American Association for Thoracic Surgery.